WELL Competitors

WELL Stock

CAD 3.96 0.05 1.25%

WELL Health Technologies competes with Extendicare, Sienna Senior, Cronos, Medical Facilities, and Quipt Home; as well as few others. The company operates under Health Care Providers & Services sector and is part of Health Care industry. Analyzing WELL Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of WELL Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out WELL Health Correlation with its peers.

WELL Health vs Quipt Home Correlation

Good diversification

The correlation between WELL Health Technologies and QIPT is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding WELL Health Technologies and QIPT in the same portfolio, assuming nothing else is changed.

Moving together with WELL Stock

0.81	NVDA	NVIDIA CDR	Pair Corr
0.81	NVDA	Nvidia CDR	Pair Corr

Moving against WELL Stock

0.72	RGSI	Rockpoint Gas Storage	Pair Corr
0.49	POU	Paramount Resources	Pair Corr
0.32	STLR	STLLR Gold	Pair Corr
0.32	NWH-UN	NorthWest Healthcare	Pair Corr

At this time, WELL Health's Return On Tangible Assets are very stable compared to the past year. As of the 1st of February 2026, Return On Assets is likely to grow to 0.02, though Return On Capital Employed is likely to grow to (0.02). At this time, WELL Health's Return On Tangible Assets are very stable compared to the past year. As of the 1st of February 2026, Fixed Asset Turnover is likely to grow to 13.05, though Net Tangible Assets are likely to grow to (289.2 M).

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
1.59	3.96	6.33

Details

Intrinsic

Valuation

Low	Real	High
1.09	3.46	5.83

Details

Naive

Forecast

Low	Next	High
1.42	3.79	6.16

Details

Earnings

Estimates (0)

Low	Projected EPS	High
0.09	0.10	0.12

Details

WELL Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between WELL Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of WELL and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of WELL Health Technologies does not affect the price movement of the other competitor.

	EXE	SIA	CRON	DR	PHA	QIPT
EXE		0.82	0.35	0.61	-0.13	0.53	EXE
SIA	0.82		0.09	0.54	-0.03	0.67	SIA
CRON	0.35	0.09		0.4	-0.03	0.4	CRON
DR	0.61	0.54	0.4		-0.26	0.54	DR
PHA	-0.13	-0.03	-0.03	-0.26		0.11	PHA
QIPT	0.53	0.67	0.4	0.54	0.11		QIPT
	EXE	SIA	CRON	DR	PHA	QIPT

High positive correlations

SIA	+ 0.82	EXE
QIPT	+ 0.67	SIA
DR	+ 0.61	EXE
DR	+ 0.54	SIA
QIPT	+ 0.54	DR
QIPT	+ 0.53	EXE

High negative correlations

PHA	- 0.26	DR
PHA	- 0.13	EXE
PHA	- 0.03	CRON
PHA	- 0.03	SIA

Risk-Adjusted Indicators

There is a big difference between WELL Stock performing well and WELL Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze WELL Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EXE	1.51	0.57	0.39	1.30	0.93	(1.95)	2.88	(2.21)	18.92
SIA	0.91	0.19	0.16	(0.58)	0.68	(1.21)	2.79	(1.49)	5.50
CRON	2.06	(0.06)	0.00	(0.05)	0.00	0.00	4.53	(3.40)	21.52
DR	1.16	0.04	0.01	0.21	1.35	(1.34)	3.05	(2.21)	8.99
PHA	7.08	0.39	0.02	0.30	8.52	(23.83)	25.00	(20.00)	53.33
QIPT	1.98	0.53	0.20	(1.06)	1.73	(2.63)	4.92	(3.23)	30.99

WELL Health Competitive Analysis

The better you understand WELL Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, WELL Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across WELL Health's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	WELL	EXE	SIA	CRON	DR	PHA	QIPT
	1.25 3.96 WELL	0.43 23.19 Extendicare	0.70 21.21 Sienna	2.86 3.40 Cronos	0.53 15.17 Medical	16.67 0.03 Premier	1.25 4.87 Quipt
Market Volatility (90 Days Market Risk)	Moderately volatile	Very steady	Very steady	Relatively risky	Not too volatile	Out of control	Relatively risky
Market Performance (90 Days Performance)	Weakest	Solid	Good	Weakest	Soft	Soft	Good
Odds of Financial Distress (Probability Of Bankruptcy)	Average	Low	Small	High	Low	Moderate	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Under Valued	Fairly Valued	Under Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Hold	Strong Buy	Cautious Hold	Hold	Cautious Hold	Strong Sell	Hold
Current Ratio	1.14 X	1.04 X	0.58 X	4.36 X	1.73 X	1.05 X	N/A
Net Asset	1.81 B	719.79 M	1.86 B	1.17 B	346.29 M	73.72 M	425.45 M
Profit Margin	(0.02) %	0.06 %	0.04 %	0.27 %	0.24 %	(0.15) %	(0.04) %
EBITDA	122.52 M	155.27 M	150.27 M	(45.37 M)	82.57 M	4.83 M	48.32 M
Operating Margin	0.1 %	0.09 %	0.11 %	(0.14) %	0.15 %	(0.15) %	(0.02) %
Current Valuation	1.51 B	2.38 B	3.25 B	226.57 M	297.18 M	45.91 M	357.15 M
Price To Book	1.21 X	13.45 X	3.23 X	0.91 X	2.33 X	1.19 X	1.56 X
Retained Earnings	(30.98 M)	(352.55 M)	(624.94 M)	457.71 M	(195.38 M)	(11.47 M)	(252.22 M)
Current Asset	N/A	211.37 M	48.59 M	N/A	129.89 M	N/A	N/A
Five Year Return	N/A	5.98 %	5.64 %	N/A	9.34 %	N/A	N/A
Beta	1.3	1.17	1.05	1.06	0.28	0.035	0.48
Number Of Employees	N/A	31	25	459	N/A	N/A	1.6 K
Shares Outstanding	253.88 M	94.46 M	94.1 M	382.89 M	18.05 M	55.51 M	44.33 M
Cash Flow From Operations	9.52 M	143.64 M	159.91 M	18.84 M	83.28 M	5.93 M	52.71 M
Annual Yield	N/A	0.02 %	0.04 %	N/A	0.02 %	N/A	N/A
Total Debt	425.09 M	292.49 M	1.01 B	2.02 M	73.94 M	46.16 M	118.79 M
Return On Equity	-0.0307	0.66	0.0707	0.0367	0.61	-14.74	-0.0965
Return On Asset	0.0193	0.1	0.0271	-0.0139	0.11	-0.0978	-0.01
Number Of Shares Shorted	7.55 M	1.96 M	797.99 K	2.98 M	60.74 K	400	731 K
Book Value Per Share	3.33 X	1.96 X	6.65 X	3.83 X	6.36 X	(0.20) X	3.13 X
Current Liabilities	N/A	218.02 M	86.47 M	N/A	44.15 M	N/A	N/A
Total Asset	1.81 B	719.79 M	1.86 B	1.17 B	346.29 M	73.72 M	425.45 M
Debt To Equity	0.48 %	6.07 %	2.33 %	0.01 %	1.22 %	0.81 %	N/A
Short Ratio	6.17 X	8.64 X	2.10 X	8.80 X	3.09 X	0.02 X	7.95 X
Target Price	7.62	25.25	22.94	4.15	15.84	0.2	5.8
Last Dividend Paid	N/A	0.49	0.94	N/A	0.24	N/A	N/A
Shares Owned By Institutions	3.99 %	34.91 %	21.80 %	15.85 %	11.57 %	N/A	54.68 %
Market Capitalization	1.01 B	2.19 B	2 B	1.3 B	278.27 M	1.39 M	215.89 M
Price To Earnings To Growth	(1.32) X	N/A	N/A	(0.54) X	0.86 X	N/A	N/A
Price To Earning	N/A	26.74 X	161.06 X	20.66 X	19.72 X	64.37 X	N/A
Price To Sales	0.80 X	1.38 X	2.06 X	9.84 X	0.83 X	0.01 X	0.88 X
Net Income	29.1 M	75.21 M	38.4 M	40.02 M	105.56 M	(12.49 M)	(10.7 M)
Earnings Per Share	(0.09) X	1.06 X	0.44 X	0.15 X	2.65 X	(0.20) X	(0.33) X
Shares Owned By Insiders	21.16 %	0.47 %	0.09 %	47.20 %	N/A	42.81 %	21.70 %
Revenue	919.69 M	1.47 B	893.16 M	117.5 M	331.53 M	158.19 M	343.09 M
Working Capital	(35.96 M)	(49.18 M)	(223.24 M)	886.41 M	76.39 M	(21.09 M)	N/A
Cash And Equivalents	131.67 M	121.85 M	179.45 M	858.8 M	108.5 M	5.52 M	N/A
Cash Per Share	0.25 X	1.36 X	2.68 X	3.34 X	2.57 X	0.10 X	N/A
Gross Profit	524.66 M	227.52 M	185.67 M	51.29 M	129.32 M	16.61 M	177.18 M
Day Typical Price	3.97	23.07	21.21	3.43	15.19	0.025	4.85
Accumulation Distribution	0.02	0.0279	0.0191	0.0258	0.0202	N/A	0.0103
Market Facilitation Index	0.08	0.65	0.41	0.09	0.31	N/A	0.05
Daily Balance Of Power	(0.62)	(0.15)	(0.37)	(1.11)	0.2581	0	1.2
Period Momentum Indicator	(0.05)	(0.10)	(0.15)	(0.10)	0.08	(0.01)	0.06
Rate Of Daily Change	0.99	1.0	0.99	0.97	1.01	0.83	1.01
Day Median Price	3.97	23.01	21.22	3.45	15.2	0.025	4.85
Price Action Indicator	(0.04)	0.14	(0.08)	(0.1)	0.015	(0)	0.055
Relative Strength Index	40.19	67.24	57.13	42.9	49.1	47.9	66.8
Coefficient Of Variation	(627.15)	421.2	641.52	(11,468)	2641.1	2706.35	807.68
Mean Deviation	1.72	1.51	0.9132	2.06	1.16	7.08	1.98
Jensen Alpha	(0.42)	0.5727	0.1923	(0.06)	0.0431	0.393	0.5317
Total Risk Alpha	(0.51)	0.4667	0.1221	(0.19)	(0.03)	(0.15)	0.31
Sortino Ratio	N/A	0.3926	0.161	N/A	0.0113	0.0204	0.1969
Downside Variance	N/A	1.99	0.827	N/A	2.2	401.39	5.94
Standard Deviation	2.39	2.52	1.23	3.11	1.63	12.3	4.24
Kurtosis	3.88	20.04	1.1	7.82	1.94	0.7555	32.56
Potential Upside	3.17	2.88	2.79	4.53	3.05	25.0	4.92
Treynor Ratio	(0.51)	1.3	(0.58)	(0.05)	0.2112	0.3011	(1.06)
Maximum Drawdown	11.63	18.92	5.5	21.52	8.99	53.33	30.99
Variance	5.71	6.36	1.51	9.64	2.65	151.33	17.96
Market Risk Adjusted Performance	(0.50)	1.31	(0.57)	(0.04)	0.2212	0.3111	(1.05)
Risk Adjusted Performance	(0.11)	0.1788	0.1168	0.0014	0.0329	0.0361	0.0978
Skewness	0.4384	3.5	0.9286	1.86	0.8298	0.4685	4.81
Semi Deviation	N/A	0.9276	0.677	N/A	1.35	8.52	1.73
Information Ratio	(0.18)	0.2196	0.1193	(0.02)	0.0103	0.0333	0.1132
Value At Risk	(3.88)	(2.21)	(1.49)	(3.40)	(2.21)	(20.00)	(3.23)
Expected Short fall	N/A	(1.95)	(1.21)	N/A	(1.34)	(23.83)	(2.63)
Downside Deviation	N/A	1.41	0.9094	N/A	1.48	20.03	2.44
Semi Variance	N/A	0.8604	0.4583	N/A	1.83	72.52	2.99

WELL Health Competition Performance Charts

Five steps to successful analysis of WELL Health Competition

WELL Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by WELL Health Technologies in relation to its competition. WELL Health's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of WELL Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact WELL Health's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to WELL Health Technologies, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your WELL Health position

In addition to having WELL Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sports Thematic Idea Now

Sports

Companies in sporting activities arena as well as manufacturers of sporting goods and sport retailers. The Sports theme has 25 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sports Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in WELL Stock

WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

WELL Competitors

WELL Health vs Quipt Home Correlation

Good diversification

Moving together with WELL Stock

Moving against WELL Stock

Specify up to 10 symbols:

WELL Health Competition Correlation Matrix

High positive correlations

High negative correlations

Risk-Adjusted Indicators

WELL Health Competitive Analysis

WELL Health Competition Performance Charts

Five steps to successful analysis of WELL Health Competition

Complement your WELL Health position

Did You Try This Idea?

Run Sports Thematic Idea Now

Sports

Other Information on Investing in WELL Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY